Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration

Journal of Neuroscience Research

Volumn 49, Issue 6, 1997, Pages 681-697

  Mattson, Mark P ^a,b   Goodman, Yadong ^a   Luo, Hong ^a   Fu, Weiming ^a   Furukawa, Katsutoshi ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Amyloid peptide; Ceramide; Decoy DNA; Hippocampal neuron; Lipid peroxidation; Transcription factor; Tumor necrosis factor; Uric acid

Indexed keywords

AMYLOID BETA PROTEIN; ANTIBODY; CERAMIDE; CYTOKINE; DNA; FERROUS SULFATE; GLUTAMATE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; MEMBRANE LIPID; PEROXYNITRITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE; URIC ACID; DRUG DERIVATIVE; ENZYME INHIBITOR; N ACETYLSPHINGOSINE; N-ACETYLSPHINGOSINE; NITRATE; NITROGEN DERIVATIVE; OXIDIZING AGENT; PEROXYNITRIC ACID; SCAVENGER; SPHINGOSINE; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIAGNOSIS; ELECTROPHORETIC MOBILITY; EMBRYO; ENZYME INDUCTION; ETIOLOGY; FLUORESCENCE; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LIPID PEROXIDATION; NEUROPROTECTION; NITRATION; NONHUMAN; OXIDATIVE STRESS; PREVENTION; PRIORITY JOURNAL; RAT; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; METABOLISM; NERVE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DNA; ENZYME ACTIVATION; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; HIPPOCAMPUS; LIPID PEROXIDATION; NEURONS; NF-KAPPA B; NITRATES; NITROGEN COMPOUNDS; OXIDANTS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SPHINGOSINE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE; URIC ACID;

EID: 0030611750     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3     Document Type: Article

References (93)

1. Andrews NC, Faller DV (1991): A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499.
2. Baeuerle PA, Henkel T (1994): Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141-179.
3. Ballou LR, Laulederkind SJ, Rosloniec EF, Raghow R (1996): Ceramide signalling and the immune response. Biochim Biophys Acta 1301:273-287.
4. Barger SW, Mattson MP (1996): Secreted form of the Alzheimer's β-amyloid precursor induces neuroprotective κB-dependent transcription. Mol Brain Res 40:116-126.
5. 2+ accumulation. Proc Natl Acad Sci USA 92-9328-9332.
6. Beckman JS, Koppenol WH (1996): Nitric oxide, Superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 271:C1424-1437.
7. Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR (1994): Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 375:81-88.
8. Beg AA, Baltimore D (1996): An essential role for NF-κB in preventing TNFα induced cell death. Science 274:782-784.
9. Behl C, Davis JB, Lesley R, Schubert D (1994): Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827.
10. Benzi G, Moretti A (1995): Are reactive oxygen species involved in Alzheimer's disease? Neurobiol Aging 16:661-674.
11. Bowling AC, Beal MF (1995): Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci 56:1151-1171.
12. Bredt DS, Snyder SH (1992): Nitric oxide, a novel neuronal messenger. Neuron 8:3-11.
13. Brown RH (1995): Superoxide dismutase in familial amyotrophic lateral sclerosis: Models for gain of function. Curr Opin Neurobiol 5:841-846.
14. Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW, Mattson MP (1996): Altered neuronal and microglial responses to brain injury in mice lacking TNF receptors. Nat Med 2:788-794.
15. Butterfield D, Hensley K, Harris M, Mattson M, Carney J (1994): β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence specific fashion: Implications to Alzheimer's disease. Biochem Biophys Res Commun 200:710-715.
16. Cheng B, Christakos S, Mattson MP (1994): Tumor necrosis factors protect neurons against excitotoxic/metabolic insults and promote maintenance of calcium homeostasis. Neuron 12:139-153.
17. Crow JP, Beckman JS (1996): The importance of Superoxide in nitric oxide-dependent toxicity: Evidence for peroxynitrite-mediated injury. Adv Exp Med Biol 387:147-161.
18. Das KC, Lewis-Molock Y, White CW (1995): Thiol modulation of TNFα and IL-1 induced MnSOD gene expression and activation of NF-κB. Mol Cell Biochem 148:45-57.
19. Davalos A, Fernandez-Real JM, Ricart W, Soler S, Molins A, Planas E, Genis D (1994): Iron-related damage in acute ischemic stroke. Stroke 25:1543-1546.
20. Eddy LJ, Goeddel DV, Wong GH (1992): Tumor necrosis factor-α pretreatment is protective in a rat model of myocardial ischemiareperfusion injury. Biochem Biophys Res Commun 184:1056-1059.
21. Estevez AG, Radi R, Barbeito L, Shin JT, Thompson JA, Beckman JS (1995): Peroxynitrite-induced cytotoxicity in PC12 cells: Evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J Neurochem 65:1543-1550.
22. Good PF, Werner P, Hsu A, Olanow CW, Perl DP (1996): Evidence for neuronal oxidative damage in Alzheimer's disease. Am J Pathol 149:21-28.
23. Goodman Y, Mattson MP (1994): Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp Neurol 128:1-12.
24. Goodman Y, Mattson MP (1996): Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity. J Neurochem 66:869-872.
25. Goodman Y, Steiner MR, Steiner SM, Mattson MP (1994): Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res 654:171-176.
26. Goodman Y, Bruce AJ, Cheng B, Mattson MP (1996): Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid β-peptide toxicity in hippocampal neurons. J Neurochem 66:1836-1844.
27. Grilli M, Pizzi M, Memo M, Spano P (1996a): Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science 274:1383-1385.
28. Grilli M, Goffi F, Memo M, Spano P (1996b): Interleukin-1β and glutamate activate the NF-κB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem 271:15002-15007.
29. Hu J, El-Fakahany EE (1993): β-Amyloid 25-35 activates nitric oxide synthase in a neuronal clone. NeuroReport 4:760-762.
30. Jesberger JA, Richardson JS (1991): Oxygen free radicals and brain dysfunction. Int J Neurosci 5:1-17.
31. Kaltschmidt C, Kaltschmidt B, Baeuerle PA (1993): Brain synapses contain inducible forms of the transcription factor NF-κB. Mech Dev 43:135-147.
32. Kaltschmidt C, Kaltschmidt B, Neumann H, Wekerle H, Baeuerle PA (1994): Constitutive NF-κB activity in neurons. Mol Cell Biol 14:3981-3992.
33. Kaltschmidt C, Kaltschmidt B, Baeuerle PA (1995): Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. Proc Natl Acad Sci USA 92:9618-9622.
34. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C (1997): Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer's disease. Proc Natl Acad Sci USA 94:2642-2647.
35. Kamii H, Mikawa S, Murakami K, Kinouchi H, Yoshimoto T, Reola L, Carlson E, Epstein CJ, Chan PH (1996): Effects of nitric oxide synthase inhibition on brain infarction in SOD-1-transgenic mice following transient focal cerebral ischemia. J Cereb Blood Flow Metab 16:1153-1157.
36. Kolesnick R, Golde DW (1994): The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77:325-328.
37. Kooy NW, Royall JA, Ischoropoulos H, Beckman JS (1994): Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic Biol Med 16:149-156.
38. Korner M, Rattner A, Mauxion F, Sen R, Citri Y (1989): A brain-specific transcription activator. Neuron 3:563-572.
39. Kruman I, Bruce AJ, Bredesen DE, Waeg G, Mattson MP (1997): Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 17:5089-5100.
40. Le W-D, Colom LV, Xie W-J, Smith RG, Alexianu M, Appel SH (1995): Cell death induced by β-amyloid 1-40 in MES 23.5 hybrid clone: The role of nitric oxide and NMDA-gated channel activation leading to apoptosis. Brain Res 686:49-60.
41. Lee S, Williams J, Lothman EW, Szele FG, Chesselet MF, Sapolsky RM, Mattson MP, Christakos S (1997): Early induction of mRNA for calbindin-D28k and BDNF but not NT-3 in rat hippocampus after kainic acid treatment. Mol Brain Res 47:183-194.
42. Lewis-Molock Y, Suzuki K, Taniguchi N, Nguyen DH, Mason RJ, White CW (1994): Lung manganese Superoxide dismutase increases during cytokine-mediated protection against pulmonary oxygen toxicity in rats. Am J Respir Cell Mol Biol 10:133-141.
43. Liu XH, Kato H, Nakata N, Kogure K, Kato K (1993): An immunohistochemical study of copper/zinc Superoxide dismutase and manganese Superoxide dismutase in rat hippocampus after transient cerebral ischemia. Brain Res 625:29-37.
44. Liu T, Clark RK, McDonnell PC, Young PR, White MS, Barone FC, Feuerstein GZ (1994): Tumor necrosis factor-α expression in ischemic neurons. Stroke 25:1481-1488.
45. Liu Z-G, Hsu H, Goeddel DV, Karin M (1996): Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565-576.
46. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW (1993): Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 90:7951-7955.
47. Lovell MA, Ehmann WD, Butler SM, Markesbery WR (1995): Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45:1594-1601.
48. Marchetti P, Hirsch T, Zamzami N, Castedo M, Decaudin D, Susin SA, Masse B, Kroemer G (1996): Mitochondrial permeability transition triggers lymphocyte apoptosis. J Immunol 157:4830-4836.
49. 2+ homeostasis and cell death. J Neurosci 15:6239-6249.
50. +-ATPase activity in hippocampal neurons. Brain Res 756:205-214.
51. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP (1997b): A role for 4-hydroxynonenal in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J Neurochem 68:255-264.
52. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP (1997c): Amyloid β-peptide impairs glucose uptake in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation. J Neurosci 17:1046-1054.
53. Mattson MP (1990): Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and calcium influx in cultured hippocampal neurons. Neuron 4:105-117.
54. Mattson MP, Furukawa K (1996): Programmed cell life: Anti-apoptotic signaling and therapeutic strategies in neurodegenerative disorders. Rest Neurol Neurosci 9:191-205.
55. Mattson MP, Rychlik B, Chu C, Christakos S (1991): Evidence for calcium-reducing and excitoprotective roles for the calcium binding protein (calbindin-D28k) in cultured hippocampal neurons. Neuron 6:41-51.
56. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992): β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12:379-389.
57. Mattson MP, Tomaselli K, Rydel RE (1993a): Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res 621:35-49.
58. Mattson MP, Kumar K, Cheng B, Wang H, Michaelis EK (1993b): Basic FGF regulates the expression of a functional 71 kDa NMDA receptor protein that mediates calcium influx and neurotoxicity in cultured hippocampal neurons. J Neurosci 13:4575-4588.
59. Mattson MP, Cheng B, Baldwin S, Smith-Swintosky VL, Keller J, Geddes JW, Scheff SW, Christakos S (1995): Brain injury and tumor necrosis factors induce expression of calbindin D-28k in astrocytes: A cytoprotective response. J Neurosci Res 42:357-370.
60. Mattson MP, Furukawa K, Bruce AJ, Mark RJ, Blanc E (1996): Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia. In Tanzi RE, Wasco W (eds): "Molecular Mechanisms of Dementia." Totowa, NJ: Humana Press, pp 103-143.
61. Meberg PJ, Kinney WR, Valcourt EG, Routtenberg A (1996): Gene expression of the transcription factor NF-κB in hippocampus: Regulation by synaptic activity. Mol Brain Res 38:179-190.
62. Moccoci P, MacGarvey MS, Beal MF (1994): Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36:747-751.
63. Natarajan K, Singh S, Burke TR, Grunberger D, Aggarwal BB (1996): Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc Natl Acad Sci USA 93:9090-9095.
64. Palmer C, Roberts RL, Bero C (1994): Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke 25:1039-1045.
65. Ratan RR, Murphy TH, Baraban JM (1994): Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione. J Neurosci 14:4385-4392.
66. Reddy SA, Chaturvedi MM, Darnay BG, Chan H, Higuchi M, Aggarwal BB (1994): Reconstitution of nuclear factor κB activation induced by tumor necrosis factor requires membrane-associated components. Comparison with pathway activated by ceramide. J Biol Chem 269:25369-25372.
67. Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, Suter M, Walter P, Yaffee M (1995): Oxidants in mitochondria: From physiology to diseases. Biochim Biophys Acta 1271: 67-74.
68. Rothe M, Pan M-G, Henzel WJ, Ayres TM, Goeddel DV (1995): The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83:1243-1252.
69. Salminen A, Liu PK, Hsu CY (1995): Alteration of transcription factor binding activities in the ischemic rat brain. Biochem Biophys Res Commun 212:939-944.
70. Schreck R, Baeuerle PA (1994): Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-κB. Methods Enzymol 234:151-163.
71. Schulz JB, Matthews RT, Beal MF (1995): Role of nitric oxide in neurodegenerative diseases. Curr Opin Neurol 8:480-486.
72. Schulz JB, Weller M, Klockgether T (1996): Potassium deprivation-induced apoptosis of cerebellar granule neurons: A sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J Neurosci 16:4696-4706.
73. Sharma HW, Narayanan R (1996): The NF-κB transcription factor in oncogenesis. Anticancer Res 16:589-596.
74. Shearman M, Hawthin S, Taylor V (1995): The intracellular component of cellular 3-(4;5-dimethylthiazol-2-yl)-2:5-diphenyltetrazoliumj bromide (MTT) reduction is specifically inhibited by B-amyloid peptides. J Neurochem 65:218-227.
75. Shu H-B, Takeuchi M, Goeddel DV (1996): The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci USA 93:13973-13978.
76. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR (1991): Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer's disease. Proc Natl Acad Sci USA 88:10540-10543.
77. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G (1997): Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17:2653-2657.
78. Szabo C (1996): Physiological and pathophysiological roles of nitric oxidein the central nervous system. Brain Res Bull 41:131-141.
79. Szabo C, Zingarelli B, Salzman AL (1996): Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ Res 78:1051-1063.
80. Taglialatela G, Robinson R, Perez-Polo JR (1997): Inhibition of nuclear factor kappa B (NFκB) activity induces nerve growth factor-resistant apoptosis in PC12 cells. J Neurosci Res 47:155-162.
81. Tanaka H, Vickart P, Bertrand JR, Rayner B, Morvan F, Imbach JL, Paulin D, Malvy C (1994): Sequence-specific interaction of α-β-anomeric double-stranded DNA with the p50 subunit of NF-κB: Application to the decoy approach. Nucleic Acids Res 22:3069-3074.
82. Tchelingerian JL, Quinonero J, Booss J, Jacque C (1993): Localization of TNFα and IL-1 alpha immunoreactivities in striatal neurons after surgical injury to the hippocampus. Neuron 10:213-224.
83. Terai K, Matsuo A, McGeer PL (1996): Enhancement of immunoreactivity for NF-κB in the hippocampal formation and cerebral cortex of Alzheimer's disease. Brain Res 735:159-168.
84. Unlap T, Jope RS (1995): Inhibition of NFκB DNA binding activity by glucocorticoids in rat brain. Neurosci Lett 198:41-44.
85. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM (1996): Suppression of TNFα-induced apoptosis by NF-κB. Science 274:787-789.
86. Wan XS, Devalaraja MN, St Clair DK (1994): Molecular structure and organization of the human manganese Superoxide dismutase gene. DNA Cell Biol 13:1127-1136.
87. Wang C-Y, Mayo MW, Baldwin AS (1996): TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274:784-787.
88. Wong GH (1995): Protective roles of cytokines against radiation: Induction of mitochondrial MnSOD. Biochim Biophys Acta 1271:205-209.
89. Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, Fitzgerald MF, Rothstein TL, Sherr DH, Sonenshein GE (1996): Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J 15:4682-4690.
90. Van SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith MA, Perry G, Godman GC, Nawroth P, Zweier JL, Stern D (1995): Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nat Med 1:693-699.
91. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B, Kroemer G (1995): Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 182:367-377.
92. Zhang Y, Tatsuno T, Carney J, Mattson MP (1993): Basic FGF, NGF, and IGFs protect hippocampal neurons against iron-induced degeneration. J Cereb Blood Flow Metab 13:378-388.
93. Zhou Y, Gopalakrishnan V, Richardson JS (1996): Actions of neurotoxic β-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists. J Neurochem 67:1419-1425.